Skip to main content
Premium Trial:

Request an Annual Quote

SeekIn Gets CE Mark for Leukemia Molecular Karyotyping Kit

NEW YORK — SeekIn said on Thursday that it has received CE marking for its LeukoPrint Molecular Karyotyping Kit for the diagnosis and stratification of leukemia patients.

LeukoPrint uses shallow whole-genome sequencing to identify copy number aberrations (CNA) in blood samples from leukemia patients to assist in diagnostic classification and risk stratification.

"LeukoPrint provides a cost-effective and simplified method for prompt and accurate CNA profiling in leukemia patients … [using] a standardized protocol which can be readily extended to clinical laboratories worldwide," SeekIn Founder and CEO Mao Mao said in a statement. By detecting CNAs of short DNA fragments and incorporating that with routine diagnostic methods, LeukoPrint can benefit conventional cytogenetics by improving diagnostic yield, Mao added.

Earlier this year, Shenzhen, China-based SeekIn received the CE mark for its SeekInCare Cancer Detection Kit for early cancer detection.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.